1. Home
  2. IPHA vs AVD Comparison

IPHA vs AVD Comparison

Compare IPHA & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.73

Market Cap

174.2M

Sector

Health Care

ML Signal

HOLD

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$3.93

Market Cap

144.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPHA
AVD
Founded
1999
1969
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
174.2M
144.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IPHA
AVD
Price
$1.73
$3.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$5.00
$12.00
AVG Volume (30 Days)
24.2K
203.9K
Earning Date
09-17-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,839,695.00
$530,073,000.00
Revenue This Year
$22.29
N/A
Revenue Next Year
$43.90
$3.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$3.28
52 Week High
$2.63
$6.33

Technical Indicators

Market Signals
Indicator
IPHA
AVD
Relative Strength Index (RSI) 37.10 32.81
Support Level $1.64 $3.84
Resistance Level $1.94 $4.48
Average True Range (ATR) 0.08 0.20
MACD -0.01 -0.03
Stochastic Oscillator 29.41 5.66

Price Performance

Historical Comparison
IPHA
AVD

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: